#215 IT: Clario Innovation Theater: Responsibly Advancing the Use of Artificial Intelligence (AI) in Clinical Trials - Current Landscape, Common Misconceptions, and Future Opportunities

#215 IT: Clario Innovation Theater: Responsibly Advancing the Use of Artificial Intelligence (AI) in Clinical Trials - Current Landscape, Common Misconceptions, and Future Opportunities

Tuesday, June 18, 2024 9:15 AM to 9:45 AM · 30 min. (US/Pacific)
Exhibit Hall Theater #1
19: InnovationTheaters

Information

AI can help optimize operations, strengthen patient privacy, and improve data quality while reducing risks of human error in clinical trials. However, AI must be used responsibly and governed by the highest ethical principles with regard for data privacy and reducing bias in algorithm performance. Delve into the transformative role of AI in clinical trials: current industry status, common misconceptions, proactively tackling bias and navigating the evolving regulatory landscape.
Clario1602Clario is a leading healthcare research and technology company that generates the highest quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence-generation solutions that combine eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Clario's science, technology, and operational experts have helped deliver over 26,000 trials and contributed to over 800 regulatory approvals in more than 100 countries. For more than 50 years, we have provided deep scientific expertise and the broadest endpoint technologies to help transform lives around the world.

Registered attendees

AS
Abi Seifert
Global Head Country Development QualityNovartis
AS
Ayush Sood
Post-Doctoral Fellow, MASC, Clinical Development and Medical AffairsBoehringer-Ingelheim Pharmaceuticals, Inc.
Bill Byrom
Bill Byrom
Vice President, Product Intelligence and Positioning; Principal, eCOA ScienceSignant Health

Log in

See all the content and easy-to-use features by logging in or registering!